股票行情快报：蓝帆医疗（002382）5月20日主力资金净卖出472.63万元

Core Viewpoint - As of May 20, 2025, BluFan Medical (002382) closed at 5.38 yuan, with a 1.32% increase, indicating a positive market sentiment despite some net outflows from major funds [1] Group 1: Financial Performance - BluFan Medical reported a main revenue of 1.478 billion yuan for Q1 2025, reflecting a year-on-year increase of 1.59% [2] - The net profit attributable to shareholders was 77.022 million yuan, showing a significant year-on-year increase of 177.86% [2] - The company’s gross profit margin stood at 17.17%, which is considerably lower than the industry average of 51.08% [2] Group 2: Market Position and Valuation - The total market capitalization of BluFan Medical is 5.418 billion yuan, which is below the industry average of 10.636 billion yuan [2] - The price-to-earnings (P/E) ratio is 17.59, significantly lower than the industry average of 54.31, indicating a potentially undervalued stock [2] - The price-to-book (P/B) ratio is 0.67, which is much lower than the industry average of 3.27, suggesting strong asset value relative to market price [2] Group 3: Fund Flow Analysis - On May 20, 2025, the net outflow of major funds was 4.7263 million yuan, accounting for 8.19% of the total transaction amount [1] - Retail investors showed a net inflow of 1.4246 million yuan, representing 2.47% of the total transaction amount, indicating some retail interest in the stock [1] - Over the past five days, the trend shows fluctuating fund flows, with significant retail inflows on certain days despite major fund outflows [1]